Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaginal progesterone for prevention of preterm birth in women with symptomatic short cervix
MOH_2025-11-13_015461Phase 2Not yet recruiting
- Sponsor
- ד"ר דורון כבירי
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of progesterone in Preterm labor (PTL) and cervical shortening (2 arms), sponsored by ד"ר דורון כבירי. Primary endpoint: Spontaneous preterm birth before 37 weeks of gestation. Planned start Nov 2025; status: not yet recruiting.
02
Drugs
progesterone
03
Conditions
Preterm labor (PTL)cervical shortening
Beyond the preview
Go deeper on MOH_2025-11-13_015461.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2025-11-13_015461.